{"id":"W3029829417","doi":"10.1200/jco.2020.38.15_suppl.e15151","title":"Comparative efficacy, safety, and tolerability of immune checkpoint inhibitors (ICIs) in cancer.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Centre Hospitalier Universitaire de Sherbrooke; University of Toronto; McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Atezolizumab; Nivolumab; Tolerability; Internal medicine; Avelumab; Oncology; Adverse effect; Lung cancer; Hazard ratio; Head and neck squamous-cell carcinoma; Odds ratio; Cancer; Head and neck cancer; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0287268,0.001714599,0.00709608,0.003197163,0.0002524104,0.002497439,0.001103014,0.001688645,0.003180999],"category_scores_gemma":[0.04213701,0.0007404033,0.0352246,0.003256748,0.0006591207,0.00151757,0.001069914,0.001994794,0.0002976728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001512725,"about_ca_system_score_gemma":0.001011613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001661933,"about_ca_topic_score_gemma":0.002430156,"domain_scores_codex":[0.9789956,0.01322214,0.003800855,0.002000821,0.001662622,0.0003179874],"domain_scores_gemma":[0.9645272,0.02761664,0.00558541,0.001042819,0.0009848117,0.0002431557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","study_design_scores_codex":[0.01595212,0.00004637024,0.00971046,0.09280256,0.8575249,0.00007270773,0.00003582292,0.001473585,0.0005364814,0.0003777655,0.0008273601,0.02063988],"study_design_scores_gemma":[0.004570946,0.001250461,0.01075802,0.006581936,0.9709881,0.0001721868,0.00003158849,0.0006514911,0.0004752394,0.001028202,0.00345819,0.00003367795],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02620801,0.9653471,0.002456284,0.0007059406,0.0004511015,0.0005432698,0.002895958,0.00004207911,0.001350276],"genre_scores_gemma":[0.7768536,0.2089825,0.005411269,0.002089851,0.0007021971,0.001551013,0.00342891,0.00008000639,0.0009006992],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0287268,"threshold_uncertainty_score":0.1519237,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1782500773696352,"score_gpt":0.4831628988173155,"score_spread":0.3049128214476803,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}